프로그램
- Presidential lecture
- Plenary lecture
- Award lecture
- 연구회 심포지엄
- 학연산 심포지엄
- 초음파 세션
- Breakfast / Luncheon symposium
- 갑상선
- 골대사
- 뇌하수체/부신/생식
- 당뇨병/비만/지질(기초)
- 당뇨병/비만/지질(임상)
- 스페셜 세션
- Satellite symposium
Breakfast / Luncheon symposium
-
Luncheon symposium 1. LG화학&동아ST
11월 1일(금) 12:15-13:10, Room 1
| 12:15-12:30 |
|
The power of two: unpacking the necessity of combination therapy with Zemidapa 김보연(순천향의대) |
| 12:30-12:45 |
|
Evogliptin : A new era in diabetes treatment and clinical outcomes 김미경(계명의대) |
-
Luncheon symposium 2. 유한양행&대웅제약
11월 1일(금) 12:15-13:10, Room 2
| 12:15-12:30 |
|
Connecting the dots along the CRM disease continuum 김헌성(가톨릭의대) |
| 12:30-12:45 |
|
CGM 가이드라인과 APAC Consensus 권고안에 따른 CGM의 사용 류영상(조선의대) |
-
Breakfast symposium 1. 사노피&릴리
11월 2일(토) 07:30-08:00, Room 1
| 07:30-07:45 |
|
TBD 전재한(경북의대) |
| 07:45-08:00 |
|
Empagliflozin, holistic benefit and evidence for T2D patient 홍준화(을지의대) |
-
Breakfast symposium 2. 부광약품&현대약품
11월 2일(토) 07:30-08:00, Room 2
| 07:30-07:45 |
|
TBD 강선미(순천향의대) |
| 07:45-08:00 |
|
TBD 문준성(영남의대) |
-
Luncheon symposium 3. 유영제약&BI-LLY
11월 2일(토) 11:40-12:40, Room 1, 2
| 11:40-11:55 |
|
Revalued combination therapy for T2DM patients 김상용(조선의대) |
| 11:55-12:10 |
|
Empagliflozin at the heart of changing diabetes treatment guidelines 강신애(연세의대) |
-
Luncheon symposium 4. 노보노디스크&종근당
11월 2일(토) 11:40-12:40, Room 3
| 11:40-11:55 |
|
Latest update on the patient benefit of switching to IDegLira in T2D patients 유소연(제주의대) |
| 11:55-12:10 |
|
Synergistic combination therapy: DPP4I+SGLT2I 김부경(고신의대) |
